Effect of Timings of the Lavare Cycle on the Ventricular Washout in an In Vitro Flow Visualization Setup.


Journal

ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109

Informations de publication

Date de publication:
01 05 2021
Historique:
pubmed: 20 2 2021
medline: 6 7 2021
entrez: 19 2 2021
Statut: ppublish

Résumé

Left ventricular assist devices inherently alter the intraventricular flow field and create areas of blood stasis with potential thrombus formation. The Lavare cycle of the Medtronic HeartWare HVAD was designed to improve ventricular washout. This study aims to evaluate its effects on ventricular washout in a pulsatile in vitro setting with a focus on the timing of pump speed changes. Ventricular flow fields were obtained via particle image velocimetry in two modes: With constant left ventricular assist devices speed and with the Lavare cycle applied. The start of the Lavare cycle was shifted over an entire cardiac cycle, and ventricular washout was evaluated based on velocity fields, kinetic energy, and normalized pulsatility of flow fields. The ventricular flow fields showed dependence on the timing of the Lavare cycle and interaction between speed changes and the cardiac phase. Higher apical velocity was observed for speed decreases at the late E wave and for increases at mid systole by 29% (P = 0.002) and 61% (P < 0.001), respectively. Mean apical kinetic energy for these phases also increased by 21% (P = 0.0013) and 46% (P < 0.001). The Lavare cycle generally promotes higher apical washout and can specifically generate further improved washout if speed steps are applied at the correct timing on the cardiac cycle.

Identifiants

pubmed: 33606388
doi: 10.1097/MAT.0000000000001269
pii: 00002480-202105000-00007
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

517-528

Informations de copyright

Copyright © ASAIO 2021.

Références

Kormos RL, Cowger J, Pagani FD, et al. The society of thoracic surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships. Ann Thorac Surg. 2019; 107:341–353
May-Newman K, Wong YK, Adamson R, Hoagland P, Vu V, Dembitsky W. Thromboembolism is linked to intraventricular flow stasis in a patient supported with a left ventricle assist device. ASAIO J. 2013; 59:452–455
Estep JD, Stainback RF, Little SH, Torre G, Zoghbi WA. The role of echocardiography and other imaging modalities in patients with left ventricular assist devices. JACC Cardiovasc Imaging. 2010; 3:1049–1064
Aigner P, Schweiger M, Fraser K, et al. Ventricular flow field visualization during mechanical circulatory support in the assisted isolated beating heart. Ann Biomed Eng. 2020; 48:794–804
Najjar SS, Slaughter MS, Pagani FD, et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant. 2014; 33:23–34
Strickland KC, Watkins JC, Couper GS, Givertz MM, Padera RF. Thrombus around the redesigned HeartWare HVAD inflow cannula: A pathologic case series. J Hear Lung Transplant. 2016; 35:926–930
Glass CH, Christakis A, Fishbein GA, et al. Thrombus on the inflow cannula of the HeartWare HVAD: An update. Cardiovasc Pathol. 2019; 38:14–20
Blitz A. Pump thrombosis-A riddle wrapped in a mystery inside an enigma. Ann Cardiothorac Surg. 2014; 3:450–471
Scandroglio AM, Kaufmann F, Pieri M, et al. Diagnosis and treatment algorithm for blood flow obstructions in patients with left ventricular assist device. J Am Coll Cardiol. 2016; 67:2758–2768
Liao S, Simpson B, Neidlin M, et al. Numerical prediction of thrombus risk in an anatomically dilated left ventricle: The effect of inflow cannula designs. Biomed Eng Online. 2016; 15:587–604
Liao S, Neidlin M, Li Z, Simpson B, Gregory SD. Ventricular flow dynamics with varying LVAD inflow cannula lengths: In-silico evaluation in a multiscale model. J Biomech. 2018; 72:106–115
May-Newman K, Moon J, Ramesh V, et al. The effect of inflow cannula length on the intraventricular flow field: An in vitro flow visualization study using the evaheart left ventricular assist device. ASAIO J. 2017; 63:592–603
May-Newman K, Montes R, Campos J, et al. Reducing regional flow stasis and improving intraventricular hemodynamics with a tipless inflow cannula design: An in vitro flow visualization study using the EVAHEART LVAD. Artif Organs. 2019; 43:834–848
Sorensen EN, Kon ZN, Feller ED, Pham SM, Griffith BP. Quantitative assessment of inflow malposition in two continuous-flow left ventricular assist devices. Ann Thorac Surg. 2018; 105:1377–1383
Aigner P, Schloeglhofer T, Plunger LC, et al. Malpositioning and formation of pump thrombosis of ventricular assist devices : Correlation of x-ray and CT data. Eur Soc Radiol. 20191–12
Prisco AR, Aliseda A, Beckman JA, Mokadam NA, Mahr C, Garcia GJM. Impact of LVAD implantation site on ventricular blood stagnation. ASAIO J. 2017; 63:392–400
May-Newman K, Marquez-Maya N, Montes R, Salim S. The effect of inflow cannula angle on the intraventricular flow field of the left ventricular assist device–assisted heart. ASAIO J. 2019; 65:139–147
Imamura T, Adatya S, Chung B, et al. Cannula and pump positions are associated with left ventricular unloading and clinical outcome in patients with HeartWare left ventricular assist device. J Card Fail. 2018; 24:159–166
Chivukula VK, Beckman JA, Prisco AR, et al. Left ventricular assist device inflow cannula angle and thrombosis risk. Circ Heart Fail. 2018; 11:1–9
Shah P, Birk S, Maltais S, et al. Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: An interagency registry for mechanically assisted circulatory support analysis. J Hear Lung Transplant. 2017; 36:640–649
Chivukula VK, Beckman JA, Prisco AR, et al. Small left ventricular size is an independent risk factor for ventricular assist device thrombosis. ASAIO J. 2019; 65:152–159
Larose JA, Tamez D, Ashenuga M, Reyes C. Design concepts and principle of operation of the HeartWare ventricular assist system. ASAIO J. 2010; 56:285–289
Mehra MR, Naka Y, Uriel N, et al. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med. 2017; 376:440–450
Kumar J, Elhassan A, Dimitrova G, Essandoh M. The lavare cycle: A novel pulsatile feature of the HVAD continuous-flow left ventricular assist device. J Cardiothorac Vasc Anesth. 2019; 33:1170–1171
Pirbodaghi T, Weber A, Axiak S, Carrel T, Vandenberghe S. Asymmetric speed modulation of a rotary blood pump affects ventricular unloading. Eur J Cardiothoracic Surg. 2013; 43:383–388
Essandoh M, Essandoh G, Stallkamp ED Jr, Perez WJ. Spectral Doppler analysis of the HeartMate 3 left ventricular assist device inflow: New challenges presented by the artificial pulse technology. J Cardiothorac Vasc Anesth. 2018; 32:e4–e5
Granegger M, Masetti M, Laohasurayodhin R, et al. Continuous monitoring of aortic valve opening in rotary blood pump patients. IEEE Trans Biomed Eng. 2016; 63:1201–1207
Tolpen S, Janmaat J, Reider C, Kallel F, Farrar D, May-Newman K. Programmed speed reduction enables aortic valve opening and increased pulsatility in the LVAD-assisted heart. ASAIO J. 2015; 61:540–547
Ising MS, Sobieski MA, Slaughter MS, Koenig SC, Giridharan GA. Feasibility of pump speed modulation for restoring vascular pulsatility with rotary blood pumps. ASAIO J. 2015; 61:526–532
Soucy KG, Sobieski MA, Monreal G, et al. Rotary pump speed modulation for generating pulsatile flow and phasic left ventricular volume unloading in a bovine model of chronic ischemic heart failure. J Hear Lung Transplant. 2016; 34:122–131
Chen Z, Jena SK, Giridharan GA, et al. Shear stress and blood trauma under constant and pulse-modulated speed CF-VAD operations: CFD analysis of the HVAD. Med Biol Eng Comput. 2019; 57:807–818
Wiegmann L, Thamsen B, de Zélicourt D, et al. Fluid dynamics in the HeartMate 3: Influence of the artificial pulse feature and residual cardiac pulsation. Artif Organs. 2019; 43:363–376
Zimpfer D, Strueber M, Aigner P, et al. Evaluation of the HeartWare ventricular assist device Lavare cycle in a particle image velocimetry model and in clinical practice. Eur J Cardio-thoracic Surg. 2016; 50:839–848
McCormick M, Nordsletten D, Lamata P, Smith NP. Computational analysis of the importance of flow synchrony for cardiac ventricular assist devices. Comput Biol Med. 2014; 49:83–94
Liao S, Wu EL, Neidlin M, Li Z, Simpson B, Gregory SD. The influence of rotary blood pump speed modulation on the risk of intraventricular thrombosis. Artif Organs. 2018; 42:943–953
Schlöglhofer T, Aigner P, Stoiber M, Schima H. Fixation and mounting of porcine aortic valves for use in mock circuits. Int J Artif Organs. 2013; 36:738–741
Reider C, Moon J, Ramesh V, et al. Intraventricular thrombus formation in the LVAD-assisted heart studied in a mock circulatory loop. Meccanica. 2017; 52:515–528
Mele D, Smarrazzo V, Pedrizzetti G, et al. Intracardiac flow analysis: Techniques and potential clinical applications. J Am Soc Echocardiogr. 2019; 32:319–332
Bermejo J, Martínez-Legazpi P, del Álamo JC. The clinical assessment of intraventricular flows. Annu Rev Fluid Mech. 2015; 47:315–342
Mahr C, Chivukula VK, McGah P, et al. Intermittent aortic valve opening and risk of thrombosis in ventricular assist device patients. ASAIO J. 2017; 63:425–432
Stainback RF, Estep JD, Agler DA, et al. Echocardiography in the management of patients with left ventricular assist devices: Recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2015; 28:853–909
Sorensen EN, Dees LM, Kaczorowski DJ, Feller ED. The heartware Lavare cycle: A cautionary tale. ASAIO J. 2020; 66:e114–e116

Auteurs

Thananya Khienwad (T)

From the Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.

Alexander Maurer (A)

From the Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria.

Mojgan Ghodrati (M)

From the Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria.

Thomas Schlöglhofer (T)

From the Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria.
Department for Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Francesco Moscato (F)

From the Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria.

Martin Stoiber (M)

From the Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria.

Heinrich Schima (H)

From the Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria.
Department for Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Philipp Aigner (P)

From the Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH